The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Pharmaceutical Continuous Manufacturing Market From 2026 To 2030?
The market size for pharmaceutical continuous manufacturing has seen rapid expansion in recent years. It is projected to increase from $2.69 billion in 2025 to $2.97 billion in 2026, at a compound annual growth rate (CAGR) of 10.4%. This historical growth can be attributed to several factors including rising drug demand volumes, the necessity for improved production efficiency, notable variability in batch manufacturing processes, mounting cost pressures on pharmaceutical companies, and early regulatory pilot approvals.
The pharmaceutical continuous manufacturing market is projected to experience substantial expansion in the coming years, with its size forecast to reach $4.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.4%. This anticipated growth during the forecast period is driven by factors such as the increasing adoption of PCM by major pharmaceutical companies, rising investments in smart factories, the demand for quicker scale-up and commercialization, a strong emphasis on supply chain resilience, and continuous advancements in processing equipment. Key trends expected over this period encompass a transition from batch to comprehensive end-to-end continuous production, a greater uptake of modular and adaptable manufacturing lines, an increasing focus on real-time quality assurance and control, the broadening use of continuous manufacturing for API production, and increasing regulatory backing for continuous manufacturing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Pharmaceutical Continuous Manufacturing Market?
The expanding implementation of industrial automation is projected to boost the growth of the pharmaceutical continuous manufacturing market. This automation involves utilizing control systems, such as computers or robots, to manage diverse processes and machinery within an industry, replacing or supplementing human labor. For pharmaceutical continuous manufacturing, industrial automation aids in real-time monitoring and feedback control during CM processes, which helps minimize human error and guarantee uniform product quality. For example, the International Federation of Robotics, a Germany-based professional non-profit organization, reported in its September 2023 World Robotics publication that factories globally recorded 553,052 industrial robot installations, indicating a 5% year-on-year growth rate in 2022. Thus, the rise in industrial automation is a significant driver for the pharmaceutical continuous manufacturing market’s expansion.
Which Segments Are Included In The Analysis Of The Pharmaceutical Continuous Manufacturing Market?
The pharmaceutical continuous manufacturing market covered in this report is segmented –
1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System
2) By Therapeutics Type: Large Molecule, Small Molecule
3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation
4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing
5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users
Subsegments:
1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems
2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software
3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems
Which Trends Are Impacting The Growth Of The Pharmaceutical Continuous Manufacturing Market?
Leading companies active within the pharmaceutical continuous manufacturing market are concentrating on developing advanced equipment, including continuous manufacturing lines, to secure a competitive advantage. A Continuous Manufacturing (CM) line functions as a specialized production system where raw materials are uninterruptedly converted into finished products without any breaks. For example, in January 2023, WuXi STA, a China-based contract research, development, and manufacturing organization (CRDMO), unveiled its Continuous Manufacturing (CM) line for oral solids in Wuxi City, China. This CM line, which complies with global cGMP regulations, advances oral drug development by utilizing continuous direct compression equipment for dispensing, blending, lubrication, tablet compression, and coating. Importantly, Process Analytical Technology (PAT) is integrated to provide real-time monitoring of blending uniformity, thus assuring high product quality.
Which Key Industry Participants Are Active In The Pharmaceutical Continuous Manufacturing Market?
Major companies operating in the pharmaceutical continuous manufacturing market are Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV
Read the full pharmaceutical continuous manufacturing market report here:
What Are The Leading Geographic Regions In The Pharmaceutical Continuous Manufacturing Market?
Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmaceutical Continuous Manufacturing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12123&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Continuous Manufacturing Market 2026, By The Business Research Company
Pharmaceutical Continuous Manufacturing Market Report 2026
Fill Finish Pharmaceutical Contract Manufacturing Market Report 2026
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model